TY - JOUR
T1 - Familial risks of breast and prostate cancers
T2 - Does the definition of the at risk period matter?
AU - Brandt, Andreas
AU - Bermejo, Justo Lorenzo
AU - Sundquist, Jan
AU - Hemminki, Kari
N1 - Funding Information:
This work was funded by Deutsche Krebshilfe; the Swedish Cancer Society; The Swedish Council for Working Life and Social Research.
Funding Information:
This work was funded by Deutsche Krebshilfe; the Swedish Cancer Society; The Swedish Council for Working Life and Social Research. The funding sources were not involved in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript or in the decision to submit the manuscript for publication.
PY - 2010/3
Y1 - 2010/3
N2 - Aim: 'Being at familial risk' may have different connotations in studies on familial risk of cancer. The register-based definition of a family history considers individuals with an affected relative at familial risk independently of the family member's diagnostic time. Alternatively, the individuals are classified to be at familial risk only after the diagnosis date of their relative, relevant to clinical counselling and screening situations. The aim of this study was to compare familial breast and prostate cancer risks according to the two definitions. Patients and methods: The nationwide Swedish Family-Cancer Database with information on cancers from 1958 to 2006 was used to calculate the hazard ratio of breast and prostate cancers according to family history using Cox regression. Family history was defined considering the number and type of affected relatives and the relative's diagnostic age, respectively. Individuals were considered at familial risk from their entry to the study or, alternatively, from the diagnostic time of the relative. Results: Hazard ratios were equal whether individuals were considered at risk independent of the relative's diagnostic date or only after the relative's diagnostic date. Conclusion: These results indicate that studies on familial breast or prostate cancer risk which do not take the relative's diagnosis date into account are applicable to screening and clinical counselling situations. The estimates according to the register-based definition are based on larger numbers of patients, which may be crucial for analysis of small groups such as families of multiple cases.
AB - Aim: 'Being at familial risk' may have different connotations in studies on familial risk of cancer. The register-based definition of a family history considers individuals with an affected relative at familial risk independently of the family member's diagnostic time. Alternatively, the individuals are classified to be at familial risk only after the diagnosis date of their relative, relevant to clinical counselling and screening situations. The aim of this study was to compare familial breast and prostate cancer risks according to the two definitions. Patients and methods: The nationwide Swedish Family-Cancer Database with information on cancers from 1958 to 2006 was used to calculate the hazard ratio of breast and prostate cancers according to family history using Cox regression. Family history was defined considering the number and type of affected relatives and the relative's diagnostic age, respectively. Individuals were considered at familial risk from their entry to the study or, alternatively, from the diagnostic time of the relative. Results: Hazard ratios were equal whether individuals were considered at risk independent of the relative's diagnostic date or only after the relative's diagnostic date. Conclusion: These results indicate that studies on familial breast or prostate cancer risk which do not take the relative's diagnosis date into account are applicable to screening and clinical counselling situations. The estimates according to the register-based definition are based on larger numbers of patients, which may be crucial for analysis of small groups such as families of multiple cases.
KW - Breast neoplasms
KW - Clinical counselling
KW - Familial risk
KW - Familial risk period
KW - Prostate neoplasms
UR - http://www.scopus.com/inward/record.url?scp=76049103104&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2009.11.016
DO - 10.1016/j.ejca.2009.11.016
M3 - Article
C2 - 20022238
AN - SCOPUS:76049103104
SN - 0959-8049
VL - 46
SP - 752
EP - 757
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 4
ER -